Search tool

Displaying 1701 - 1710 of 4575

Document library

EMCDDA-ECDC working arrangement, 2018

This is the updated EMCDDA–ECDC working arrangement signed in Brussels on 4 December 2018 by EMCDDA Director Alexis Goosdeel and ECDC Director Andrea Ammon.

EU 2019-2024: How can we support viral hepatitis elimination in line with the WHO Global Strategy and UN SDGs

EU drugs agency publishes its first report on the medical use of cannabis

What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue...

Medical use of cannabis and cannabinoids: questions and answers for policymaking

What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue...

Signature of working arrangement between EMCDDA and ECDC

On 4 December, Mr Goosdeel and ECDC Director Andrea Ammon sign the updated EMCDDA–ECDC working arrangement in Brussels. This follows their participation at the European Parliament in a high-level panel discussion‘EU 2019–2024...

Document library

The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic

Publication cover

A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids

This paper accompanies the report Medical use of cannabis and cannabinoids — questions and answers for policymaking and summarises the findings of major systematic reviews of the evidence on the effectiveness and...

Document library

Concurrent use of benzodiazepine by heroin users-what are the prevalence and the risks associated with this pattern of use?

Document library

FAFO, Norway (2018) Evaluation of Norway's action plan for the alcohol and drugs field 2016-20. Second status report

This document presents FAFO, Norway's second status report for the evaluation of Norway's action plan for the alcohol and drugs field 2016-20.

Document library

Review of Northern Ireland's New Strategic Direction for Alcohol and Drugs - Phase 2

This report presents the Institute of Public Health in Ireland's Review of Northern Ireland's New Strategic Direction for Alcohol and Drugs - Phase 2.